Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Moxibustion for Fetus in Breech Presentation

This study has been completed.
Swiss National Science Foundation
Loterie Romande
Information provided by:
University Hospital, Geneva Identifier:
First received: April 28, 2009
Last updated: NA
Last verified: April 2009
History: No changes posted

Objective: To evaluate moxibustion of the BL67 acupoint between 34 and 38 weeks of gestation to facilitate cephalic version of breech presentation in a Western setting. The hypothesis is that moxibustion increase the likelihood of cephalic version.

Design: Randomised controlled trial Setting: University hospital. Population: A total of 212 consenting women between 34 and 36 weeks of gestation with a single fetus in breech presentation will be randomised to moxibustion (n=106) or expectant management (n=106).

Main Outcome Measure: Cephalic presentation at delivery or before external cephalic version.

Condition Intervention Phase
Breech Presentation
Procedure: Moxibustion of the BL67 acupoint
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Care Provider)
Primary Purpose: Treatment
Official Title: Moxibustion for Fetus in Breech Presentation

Further study details as provided by University Hospital, Geneva:

Primary Outcome Measures:
  • Cephalic presentation at delivery or before external cephalic version [ Time Frame: end of pregnancy ]

Secondary Outcome Measures:
  • Mode of delivery [ Time Frame: end of pregnancy ]
  • Women's views on the intervention [ Time Frame: end of pregnancy ]
  • External cephalic version [ Time Frame: end of pregnancy ]

Enrollment: 212
Study Start Date: October 2004
Study Completion Date: January 2009
Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Moxibustion Procedure: Moxibustion of the BL67 acupoint
Moxibustion sessions every day (every other day in hospital, self-administration at home the other day) during a maximum of 14 days. Stopped if cephalic version.
No Intervention: Control


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Breech presentation
  • 34 to 36 weeks of gestation
  • Single fetus

Exclusion Criteria:

  • Uterine malformation
  • Placenta praevia
  • Transverse lie
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00890474

Hôpitaux Universitaires de Genève
Geneva, Switzerland
Sponsors and Collaborators
University Hospital, Geneva
Swiss National Science Foundation
Loterie Romande
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Marie-Julia Guittier, Hôpitaux Universitaires de Genève Identifier: NCT00890474     History of Changes
Other Study ID Numbers: Moxibustion_siege
Study First Received: April 28, 2009
Last Updated: April 28, 2009

Keywords provided by University Hospital, Geneva:
Breech presentation at 34 to 36 weeks of gestation

Additional relevant MeSH terms:
Breech Presentation
Obstetric Labor Complications
Pregnancy Complications processed this record on April 28, 2017